Related Experiment Videos
Hyperfractionated radiotherapy for diffuse intrinsic brain stem tumors in children
1McGill University, Montreal, Que., Canada.
Pediatric Neurosurgery
|January 1, 1996
Summary
Hyperfractionated radiotherapy for pediatric brain stem tumors shows best results at intermediate doses (70.2-72 Gy). Higher doses did not improve efficacy but increased complications, indicating a balanced therapeutic ratio at this level.
Area of Science:
- Pediatric Oncology
- Radiation Oncology
- Neuro-oncology
Background:
- Diffuse intrinsic brain stem tumors (DIPs) in children often fail locally.
- Conventional radiotherapy shows a dose-response relationship, suggesting higher doses may improve outcomes.
- Hyperfractionated radiotherapy allows for higher total radiation doses.
Purpose of the Study:
- To evaluate the efficacy and toxicity of escalating doses of hyperfractionated radiotherapy in children with DIPs.
- To determine the optimal dose of hyperfractionated radiotherapy with the best therapeutic ratio.
Main Methods:
- A series of Phase I/II clinical studies accrued children with DIPs since 1984.
- Escalating doses of hyperfractionated radiotherapy were tested, ranging from 64.8 Gy to 78 Gy.
- Efficacy and toxicity, including steroid dependency and intralesional necrosis, were assessed.
Main Results:
- Lowest doses (64.8-66 Gy) showed no improvement over conventional treatment with acceptable toxicity.
- Intermediate doses (70.2-72 Gy) suggested improved efficacy.
- Highest doses (75.6-78 Gy) did not yield further efficacy gains but increased treatment complications.
Conclusions:
- Intermediate doses of hyperfractionated radiotherapy (70.2-72 Gy) appear to offer the best therapeutic ratio for pediatric DIPs.
- The optimal dose is currently being evaluated in a randomized Phase III trial by the Pediatric Oncology Group.